Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by lonc17on Feb 06, 2024 11:23am
215 Views
Post# 35865336

Bankruptcy

BankruptcyONC is precariously close to bankruptcy.  As of September 30, 2023 they had one year cash on hand. 

To be fair, we need to remember the ATM. 

ONC is very likely selling as many as 50,000 shares each day into the market, which after fees would equate to a little over $1 million per month. 

Their burn rate is more than $2 million per month. 

So it is possible they might still have ten months cash as of January 31, 2024, and this ten month window could then again be extended slightly by continous access to the ATM.

Nevertheless, they are well on their way to bankruptcy. 

And every day they tap the ATM it is a downward push on the share price. 

BTW it astounds me that there are investors on this board who believe that ANSON is at this time a major shareholder of ONC. Please do just a little research and you will understand that ANSON used the bought deal financing to cover a short postion that was established in the six weeks leading up tot he placement. 

Here's the most likely scenario during next six weeks:

1. ONC will anounce a reverse split (their thrid).  It wil again be somewhere around 9.5/1 thus raising the share price to $10 U.S. 

2. ONC will simultaneously spend a gazillion dollars flooding the internet with promotional "newsy" paid for advertising promoting the miracle cure pelareorep. 

3. ONC will announce a financing that will raise $20 million U.S. and dilute existing shareholders even further.

4. MC will use these funds to keep the ights on and promise and promise and promise that one or two P3 trilas will start in the not too distant future. 

5. The BOD will give everyone on the team another boatload of options to reward them for their hard work.

6.  The share price will resume its steady decline back to $1 U.S. 


<< Previous
Bullboard Posts
Next >>